These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3294015)

  • 1. Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants.
    Tessin I; Thiringer K; Trollfors B; Brorson JE
    Eur J Pediatr; 1988 May; 147(4):405-7. PubMed ID: 3294015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants.
    Tessin I; Trollfors B; Thiringer K; Thörn Z; Larsson P
    Eur J Pediatr; 1989 Jun; 148(7):679-81. PubMed ID: 2663518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobramycin pharmacokinetics in very low birth weight infants.
    Nahata MC; Powell DA; Durrell DE; Miller MA
    Br J Clin Pharmacol; 1986 Mar; 21(3):325-7. PubMed ID: 3964533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tobramycin levels in low- and very low-birthweight infants.
    Cordero L; Arwood L; Hann C; Visconti J
    Am J Perinatol; 1984 Apr; 1(3):242-6. PubMed ID: 6525212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
    Rödjer S; Alestig K; Bergmark J; Bergström T; Hultberg B; Jagenburg R; Olaisson L; Trollfors B; Westin J
    J Antimicrob Chemother; 1987 Jul; 20(1):109-16. PubMed ID: 3305460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.
    Drusano GL; Joshi J; Forrest A; Ruxer R; Standiford H; Leslie J; Wade J; Schimpff S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):605-7. PubMed ID: 3890730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock.
    Goscinski G; Lipcsey M; Eriksson M; Larsson A; Tano E; Sjölin J
    Crit Care; 2004 Feb; 8(1):R35-41. PubMed ID: 14975053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gestational age and birth weight on tobramycin kinetics in newborn infants.
    Nahata MC; Powell DA; Durrell DE; Miller MC; Glazer JP
    J Antimicrob Chemother; 1984 Jul; 14(1):59-65. PubMed ID: 6480541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.
    van 't Veen A; Mouton JW; Gommers D; Kluytmans JA; Dekkers P; Lachmann B
    Antimicrob Agents Chemother; 1995 Feb; 39(2):329-33. PubMed ID: 7726491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with ceftazidime monotherapy in perinatal infection.
    Amato M; Schaad UB
    Helv Paediatr Acta; 1987; 42(4):297-303. PubMed ID: 3127359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime in neonatal infections.
    Low DC; Bissenden JG; Wise R
    Arch Dis Child; 1985 Apr; 60(4):360-4. PubMed ID: 3890766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosa.
    Madaras-Kelly KJ; Moody J; Larsson A; Baeker Hovde L; Rotschafer JC
    Chemotherapy; 1997; 43(2):108-17. PubMed ID: 9084919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gentamicin dosage in newborn infants].
    Sommer R; Eitelberger F; Hohenauer L
    Klin Padiatr; 1989; 201(5):387-92. PubMed ID: 2796244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.